Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares conducted on April 8, 2026. The filing was submitted on April 9, 2026. The transaction was executed by BNP Paribas SA acting as the broker under a non-discretionary agreement announced on February 17, 2026.
Key Financial Metrics
The filing details a specific share repurchase event rather than comprehensive financial results. Key metrics for the transaction are as follows:
- Shares Purchased: 330,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 2,105.00p; highest price paid was 2,140.00p.
- Volume-Weighted Average Price (VWAP): 2,125.45p.
- Treasury Shares Held: Following this purchase, the Company holds 257,457,615 ordinary shares in treasury.
- Shares in Issue: 4,058,726,834 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 6.34% of the total voting rights.
Material Changes
Since the commencement of the buyback programme on February 17, 2026, the Company has purchased a total of 17,566,521 ordinary shares. The purchase reported in this filing increased the treasury share count and reduced the number of shares in issue. The filing does not provide comparative financial data (revenue, profit, or cash flow) for the period.
Guidance, Outlook, and Risks
The filing confirms the purchase is part of the Company's existing buyback programme. No new financial guidance or operational outlook is provided in this document. The Company includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the "Risk Factors" section of the Annual Report on Form 20-F for 2025.
Important Facts for Investors
- Verify the total number of voting rights (4,058,726,834) when calculating disclosure thresholds under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
- Note that treasury shares (6.34% of voting rights) do not carry voting rights.
- Confirm the cumulative buyback volume of 17,566,521 shares since February 17, 2026.
- Review the Annual Report on Form 20-F for 2025 for detailed risk factors associated with forward-looking statements.